Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)-Reference-Cited by-同舟云学术

Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML)

Published:2020-07-29 Issue:4 Volume:35 Page:1145-1155
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Yun Seongseok,Geyer Susan M.,Komrokji Rami S.^ORCID,Al Ali Najla H.,Song Jinming,Hussaini Mohammad,Sweet Kendra L.,Lancet Jeffrey E.^ORCID,List Alan F.,Padron Eric,Sallman David A.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Cancer Institute

ASH RTAF award USF GME grant

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0997-4.pdf

Reference40 articles.

1. Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361:1872–85.

2. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341:1051–62.

3. Kayser S, Döhner K, Krauter J, Köhne CH, Horst HA, Held G, et al. The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 2011;117:2137–45.

4. Hulegårdh E, Nilsson C, Lazarevic V, Garelius H, Antunovic P, Rangert Derolf Å, et al. Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry. Am J Hematol. 2015;90:208–14.

5. Renaud L, Nibourel O, Berthon C, Roumier C, Rodriguez C, Frimat C, et al. De Novo and secondary acute myeloid leukemia, real world data on outcomes from the french nord-pas-de-calais picardie acute myeloid leukemia observatory. Blood. 2016;128:4013.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of m6A regulators to predict transformation from myelodysplastic syndrome to acute myeloid leukemia via machine learning;Medicine;2024-07-12

2. TP53 Mutations in Acute Leukemias and Myelodysplastic Syndromes: Insights and Treatment Updates;American Society of Clinical Oncology Educational Book;2024-06

3. Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC–Alarmin Axis;Blood Cancer Discovery;2024-05-07

4. Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives;Cancers;2024-04-15

5. Analysis of gene mutation characteristics and its correlation with prognosis in patients with myelodysplastic syndromes;Clinica Chimica Acta;2024-02